Clinical Trials Directory

Trials / Completed

CompletedNCT02080897

Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease

Evaluating Quality of Life in Patients With Soft Tissue Sarcoma Presenting With Metastatic Lung Disease Using the ESAS-Sarcoma Modified Questionnaire

Status
Completed
Phase
Study type
Observational
Enrollment
4 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the role of palliative surgery in improving Quality of Life (QoL) and symptom control for patients who present with a Soft Tissue Sarcoma (STS) and metastatic lung disease. Responses to clinical Edmonton Symptom Assessment System - Sarcoma Modified ( ESAS-SM) questionnaire for patients who have undergone surgery for resection of the primary tumour will be compared to those that are unable to have surgery. Data collected from this questionnaire can highlight the benefits in patients' QoL who receive palliative surgical resection, and whether these benefits surmount those who are not treated with palliative surgery.

Conditions

Timeline

Start date
2014-03-01
Primary completion
2017-08-07
Completion
2017-08-07
First posted
2014-03-07
Last updated
2018-04-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02080897. Inclusion in this directory is not an endorsement.